bioAffinity Technologies Announces Award of Hong Kong Patent

PUBLISHED ON November 15, 2016

SAN ANTONIO, TX (Nov. 15, 2016) bioAffinity Technologies announced that the government of the Hong Kong Special Administrative Region has awarded a Certificate of Grant of Standard Patent for the Company’s proprietary CyPath© technology for the early detection of lung cancer.

read more